Minimal RNA constructs that specifically bind aminoglycoside antibiotics with high affinities

Biochemistry
K HamasakiR R Rando

Abstract

RNA molecules are the functional targets for aminoglycosides. In order to approach an understanding of the rules which underlie aminoglycoside-RNA recognition, high-affinity RNA aptamers have been prepared which discriminate among various aminoglycosides [Wang et al. (1996) Biochemistry 35, 12338-12346]. One of these aptamers, J6, which is 109 nts in length, binds the aminoglycoside tobramycin stoichiometrically with a dissociation constant of 0.77 +/- 0.03 nM. Aminoglycosides, similar in structure to tobramycin, bind with affinities diminished by 10(3)-10(4) compared to tobramycin. Experiments are reported here which are designed to reveal the nature of the tobramycin binding domain of J6. A small (40 nts) stem-loop derivative of J6, containing a 3 nt and a 1 nt bulge, stoichiometrically binds tobramycin with a dissociation constant of approximately 5 nM. This construct can strongly discriminate between similar aminoglycosides with respect to binding. Elimination of either the three or the single nucleotide bulge eliminates specific aminoglycoside binding. The structure of the loop region is also critical. These studies demonstrate that simplified RNA molecules can be generated which bind aminoglycosides specifically and with ...Continue Reading

References

Jan 1, 1991·Annual Review of Biochemistry·H F Noller
Jun 11, 1990·Nucleic Acids Research·R Ben Aziz, H Soreq

❮ Previous
Next ❯

Citations

May 20, 1999·Biopolymers·T Hermann, E Westhof
Mar 14, 2000·Bioorganic & Medicinal Chemistry Letters·I KumagaiH Mihara
Sep 15, 2000·Bioorganic & Medicinal Chemistry Letters·D P Arya, R L Coffee
May 17, 2001·Bioorganic & Medicinal Chemistry Letters·I KumagaiH Mihara
Apr 20, 2002·Bioorganic & Medicinal Chemistry Letters·I CharlesDev P Arya
Feb 18, 1999·Bioorganic & Medicinal Chemistry Letters·B Llano-Sotelo, C S Chow
Sep 15, 2001·Bioorganic & Medicinal Chemistry·D Grate, C Wilson
Dec 22, 1999·Current Opinion in Chemical Biology·F WalterE Westhof
Apr 25, 2000·Nucleic Acids Research·J Cho, R R Rando
May 19, 2004·Nucleic Acids Research·Dagmar KlostermeierJames R Williamson
Jul 25, 2003·Antimicrobial Agents and Chemotherapy·Marc GalimandThierry Lambert
Jun 23, 2009·RNA·Susan WeinlichDirk H Ostareck
Dec 13, 2002·Proceedings of the National Academy of Sciences of the United States of America·Klaus HartmuthReinhard Lührmann
Jul 9, 2004·Chembiochem : a European Journal of Chemical Biology·Steven H L VerhelstJacques H van Boom
May 4, 2011·Chembiochem : a European Journal of Chemical Biology·Tamaki Endoh, Naoki Sugimoto
Oct 26, 2016·Methods : a Companion to Methods in Enzymology·Ana M Matia-GonzálezAndré P Gerber
Aug 5, 2000·Journal of Molecular Biology·C BaughC Wilson
Mar 6, 2012·Bioanalytical Reviews·Beate StrehlitzRegina Stoltenburg
Apr 10, 1999·Journal of Medicinal Chemistry·T Hermann, E Westhof
Jul 10, 2019·The Journal of Physical Chemistry. B·Katyanna S BezerraJonas I N Oliveira
Nov 1, 2001·Journal of the American Chemical Society·D P AryaI Charles
Jun 8, 2001·Journal of the American Chemical Society·D P AryaA I Abramovitch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.